과다색소침착 치료 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 적응증별, 치료법별, 피부색별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Hyperpigmentation Treatment Market Growth & Trends:

The global hyperpigmentation treatment market size is expected to reach USD 2.02 billion by 2030, registering a CAGR of 6.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing awareness about skin health and the rising demand for aesthetic improvements are key drivers. Technological advancements in non-invasive treatments, such as laser therapy, chemical peels, and micro needling, have made hyperpigmentation treatments more effective and accessible. Additionally, the growing influence of social media and beauty influencers has heightened consumer awareness and desire for immaculate skin, encouraging more people to seek professional treatments. The expansion of dermatology clinics and aesthetic centers offering specialized services further supports this market growth, as more consumers are willing to invest in maintaining a youthful and radiant complexion.

Moreover, rapid advancement in aesthetic treatment technologies, innovations in laser therapy, chemical peels, microneedling, and other non-invasive procedures have significantly improved the effectiveness and safety of hyperpigmentation treatments. For instance, technologies like intense pulsed light (IPL) and fractional laser treatments offer targeted solutions with minimal downtime, attracting a broad range of consumers. Developing advanced topical treatments, such as brightening serums and creams infused with potent active ingredients, also provides non-invasive options for managing hyperpigmentation, catering to consumers' diverse preferences.

In addition, rising disposable incomes and changing lifestyle patterns contribute to the market's expansion. As more consumers gain the financial capability to invest in aesthetic procedures, the demand for hyperpigmentation treatments continues to rise. The trend is particularly evident in emerging markets, where an increasing focus accompanies economic growth on personal grooming and skincare. Additionally, cultural factors that emphasize the importance of clear and even-toned skin further fuel the demand for hyperpigmentation treatments in these regions.

Hyperpigmentation Treatment Market Report Highlights:

• The age spots segment dominated the market and held the largest revenue share of 36.6% in 2024. The melasma segment is expected to grow at the fastest CAGR of 7.1% from 2025 to 2030.
• The energy-based therapy segment dominated the market and held the largest revenue share of 68.4% in 2024. The microneedling segment is expected to grow at the fastest CAGR of 6.7% from 2025 to 2030.
• The Fitzpatrick skin type III & IV segment dominated the market and held the largest revenue share of 39.6% in 2024. This dominance is attributed to the higher prevalence of hyperpigmentation disorders in individuals with these skin types.
• The dermatology clinics segment dominated the market with a revenue share of 49.4% in 2024. This dominance is attributed to the high level of trust and expertise associated with dermatology clinics, making them the preferred choice for patients seeking professional and effective hyperpigmentation treatments.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Indication
  • 1.2.2. Treatment
  • 1.2.3. Skin Tone
  • 1.2.4. End-use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Indication Segment
  • 2.2.2. Treatment Segment
  • 2.2.3. Skin Tone Segment
  • 2.2.4. End-use Segment
  • 2.2.5. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Hyperpigmentation Treatment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Hyperpigmentation Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Global Hyperpigmentation Treatment Market: Indication Estimates & Trend Analysis

• 4.1. Hyperpigmentation Treatment Market: Indication Dashboard
• 4.2. Hyperpigmentation Treatment Market: Indication Movement Analysis
• 4.3. Hyperpigmentation Treatment Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 4.4. Age spots
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Melasma
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Post-inflammatory hyperpigmentation (PIH)
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Global Hyperpigmentation Treatment Market: Treatment Estimates & Trend Analysis

• 5.1. Hyperpigmentation Treatment Market: Treatment Dashboard
• 5.2. Hyperpigmentation Treatment Market: Treatment Movement Analysis
• 5.3. Hyperpigmentation Treatment Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
• 5.4. Energy-based Therapy
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.1.1. Laser
      • 5.4.1.1.1. Laser Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.1.2. Intense Pulse Light (IPL)
      • 5.4.1.2.1. Intense Pulse Light (IPL) Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.1.3. Others
      • 5.4.1.3.1. Others Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Chemical Peels
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Microdermabrasion
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.7. Microneedling
  • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Global Hyperpigmentation Treatment Market: Skin Tone Estimates & Trend Analysis

• 6.1. Hyperpigmentation Treatment Market: Skin Tone Dashboard
• 6.2. Hyperpigmentation Treatment Market: Skin Tone Movement Analysis
• 6.3. Hyperpigmentation Treatment Market Size & Forecasts and Trend Analysis, by Skin Tone, 2018 to 2030 (USD Million)
• 6.4. Fitzpatrick Skin Type I & II
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Fitzpatrick Skin Type III & IV
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Fitzpatrick Skin Type V & VI
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Global Hyperpigmentation Treatment Market: End-use Estimates & Trend Analysis

• 7.1. Hyperpigmentation Treatment Market: End-use Dashboard
• 7.2. Hyperpigmentation Treatment Market: End-use Movement Analysis
• 7.3. Hyperpigmentation Treatment Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 7.4. Dermatology Clinics
  • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. Aesthetic Centers
  • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.6. Hospitals & Specialty Clinics
  • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Global Hyperpigmentation Treatment Market: Regional Estimates & Trend Analysis by Country, Type, Application, Skin Type and End-use

• 8.1. Hyperpigmentation Treatment Market: Regional Dashboard
• 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Regulatory framework/ reimbursement structure
    • 8.3.4.3. Competitive scenario
    • 8.3.4.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4.9. Denmark
    • 8.4.9.1. Key country dynamics
    • 8.4.9.2. Regulatory framework/ reimbursement structure
    • 8.4.9.3. Competitive scenario
    • 8.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.3. Japan
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework/ reimbursement structure
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7.3. South Africa
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 9.2. Company/Competition Categorization
  • 9.2.1. Dermatologikum Berlin
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Application benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. Skin Deep Laser Services
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Application benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Medical Beauty Cologne
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Application benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Dermatology Private Clinic Dr. med. Aresu Naderi
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Application benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. The Harley Street Dermatology Clinic
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Application benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Premier Laser Clinic UK Ltd.
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Application benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Qazi Cosmetic Center
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Application benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. ABBY SKIN CLINIC
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Application benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. The Marbella Vein & Beauty Clinic
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Application benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Sedgh Plastic Surgery
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Application benchmarking
    • 9.2.10.4. Strategic initiatives